See also this year's filing and all EDGAR filings for this company.
PDF Report 0001553643_2024_Relmada_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001553643, Relmada Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 97,508,917 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 43,125 |
| 4 | LiabilitiesCurrent | 12,194,800 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 56,242,011 |
| 9 | ResearchAndDevelopmentExpense | 28,203,307 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,193,493 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 97,552,042 |
| 1 | Liabilities | 12,194,800 |
| 2 | Expenses | 84,445,318 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 85,357,242 |
| 5 | NetIncome | -81,251,825 |
| 6 | ComprehensiveNetIncome | -81,251,825 |
| 7 | BaseVar | 98,692,826 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.91 |
| 9 | EconomicCapitalRatio | 2.96 |
Edgar->Model Mapping
Feature Distribution
Change over Time
